Caribou Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $36.0M
Liabilities Breakdown FY2020
Total Liabilities: $18.2M
Asset Breakdown
Total Assets: $36.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $16.0M | 44.3% |
| Accounts Receivable | $150.0K | 0.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.5M | 9.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $16.4M | 45.6% |
Liabilities Breakdown
Total Liabilities: $18.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 14.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.6M | 85.7% |